 |
|
|
|
| |
News
May 17, 2010 TOLEDO, OH. LexaMed presents "Meet the Experts" on Monday, May 17, 2010 from 9am - 4pm at the Hilton Garden Inn at Levis Commons in Perrysburg, OH. Learn from present and past ISO/AAMI Sterilization Working Group Co-Chairs: Carolyn Kinsley, Philip Schneider, Robert Reich and James Kulla. The seminar will consist of four technology update sessions: (1) Ethylene Oxide Sterilization, (2) Biological Indicators, (3) Radiation Sterilization, and (4) Aseptic Processing / Manufacturing. This is a unique opportunity to learn from and discuss your specific questions with industry recognized subject matter experts! To register, contact Becky Gilsdorf at (419) 693-5307 / (888) 232-5227 or via email at bgilsdorf@lexamed.net.
BioOhio is happy to have LexaMed as an exhibitor for the March 16, 2010 Suppliers & Service Providers Expo in Columbus, OH: http://www.bioohio.com/news/Events-Calendar/Suppliers-Service-Providers-Expo.aspx
January 4, 2010 TOLEDO, OH. LexaMed is pleased to announce an addition to our BEC Growth-ChekTM Microbial Suspension product line: Staphylococcus aureus. S. aureus is a Gram-positive coccus that has recently been specified as a required challenge organism for USP growth promotion evaluations. The first lot for commercial distribution is expected to be released on January 4, 2010. Growth-Chek microbial suspensions are specially prepared for simplifying the performance of USP Growth Promotion, Monograph <71> and Bacteriostasis /Fungistasis testing and are also useful for other quality control microbial challenges. Growth-Chek suspensions have been providing quality microbial challenge suspensions to the medical products industry for over 20 years. LexaMed manufactures these suspensions in our ISO 13485 certified laboratories and ships them ready-to-use; they require no additional preparation or dilution prior to use. Each lot is derived from recognized culture collections identified in USP and ISO 11138, and is certified for purity and population (<100 organisms per dose). Further expansion of our Growth-Chek product line, including additional organisms and higher challenge concentrations, are currently under development.
LexaMed is a company dedicated to providing the medical device, pharmaceutical and biotechnology industries with quality, compliant, state-of-the-art services in the areas of consulting, auditing, training and contract laboratory services.
December 15, 2009 TOLEDO, OHIO. LexaMed Ltd., a provider of contract laboratory and consulting services to the medical device, pharmaceutical industries and related industries, announced today that it had received ISO 13485:2003 certification from SAI Global, an internationally known Notified Body registration firm. ISO 13485 is an internationally recognized standard that demonstrates that the company has the appropriate Quality Management Systems in place to consistently provide services to the medical device and related industries that meet customer and regulatory requirements.
This certification is the result of the integrated efforts and dedication of all LexaMed employees to develop and support a dynamic Quality Management Systems that continuously strives for improvement. This is consistent with LexaMed's mission statement and corporate strategy of meeting or exceeding client expectations with cost-effective quality services. LexaMed also has an ISO: 9001 certification.
Quality Laboratory Testing, Validation, Research and Development, and Consulting
©2009
LexaMed, Ltd. All Rights Reserved.